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The flexible and heterogeneous nature of carbohy-
drate chains often renders glycoproteins refractory
to traditional structure determination methods.
Small-angle X-ray scattering (SAXS) can be a useful
tool for obtaining structural information of these
systems. All-atom modeling of glycoproteins with
flexible glycan chains was applied to interpret the
solution SAXS data for a set of glycoproteins. For
simpler systems (single glycan, with a well-defined
protein structure), all-atom modeling generates
models in excellent agreement with the scattering
pattern and reveals the approximate spatial occu-
pancy of the glycan chain in solution. For more
complex systems (several glycan chains, or unknown
protein substructure), the approach can still pro-
vide insightful models, though the orientations of
glycans become poorly determined. Ab initio shape
reconstructions appear to capture the global mor-
phology of glycoproteins but in most cases offer
little information about glycan spatial occupancy.
The all-atom modeling methodology is available as
a web server at http://salilab.org/allosmod-foxs.
INTRODUCTION
The covalent addition of carbohydrate groups to proteins is one
of the most common posttranslational modifications, with over
half of the human proteome containing some degree of glyco-
sylation (Brooks, 2009). Glycosylation can stabilize proteins,
shield the underlying protein from proteases, increase solu-
bility, and often plays a critical role in cell-cell and host-path-
ogen interactions (Shental-Bechor and Levy, 2008). Despite
their importance, glycoproteins as a class remain a challenging
target for structural biology (Walsh, 2010). The high degree of
flexibility of the glycans presented on the protein surface as
well as the significant micro- and macroglycan heterogeneity
exhibited within a purified population of glycoprotein (Imberty
and Pe´rez, 2000) limits the efficacy of X-ray crystallography
as a tool for their structural determination. Glycan modifica-Structure 21,tions also limit the utility of nuclear magnetic resonance
(NMR) spectroscopy due to detrimental effects on rotational
correlation times and significant chemical shift overlap (Slynko
et al., 2009).
Small-angle X-ray scattering (SAXS) has become a versatile
tool for examining macromolecules in the native solution state.
It can be used to study disordered systems and molecules
with significant internal flexibility (Bernado´, 2010; Hammel,
2012; Jacques and Trewhella, 2010; Mertens and Svergun,
2010; Pelikan et al., 2009; Putnam et al., 2007; Rambo and
Tainer, 2010). Two caveats add a layer of complexity for
applying SAXS to study glycoproteins, namely, the different
scattering contrast of the carbohydrate relative to the protein
(Hammel et al., 2002) and the disproportionate layer of hydra-
tion associated with the sugars (Wittmann, 2007). Despite
these limitations, the low-resolution morphologies of a number
of glycoproteins determined by SAXS have been reported
(Bernocco et al., 2003; Guttman et al., 2012; Lynn et al.,
2005). While most of these studies are unable to directly visu-
alize the influence or position of the glycans, in some instances
the glycan positions appeared to be identifiable (Hammel et al.,
2002). Rigid body refinement and molecular dynamics guided
by SAXS data have been established as a method for obtain-
ing more detailed models, but the current programs are not
suited for taking glycosylation into account (Pelikan et al.,
2009).
NMR studies of isolated carbohydrate chains and molecular
dynamics have shown that significant internal flexibility exists
within glycan chains (Woods et al., 1998). All-atom force fields
have been developed for assessing the internal structures of
sugars in silico (Frank and Schloissnig, 2010; Kirschner et al.,
2008), and computational modeling has been useful for gener-
ating fully glycosylated structures using the nonglycosylated
template (Bohne-Lang and von der Lieth, 2005; Renouf and
Hounsell, 1995). However, experimental validation of these
structural models has been limited.
Here, we establish the approach of assessing large ensembles
of glycoprotein models against SAXS data to test the validity of
the models. Concurrently, we examine the reliability of SAXS
ab initio reconstruction for glycoproteins. Last, we demonstrate
the accuracy of molecular weight (MW) determination from the
SAXS intensity for glycoproteins. This report provides a guideline
and documents limitations of SAXS applied to the study of
glycoproteins.321–331, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 321
Table 1. Molecular Mass Determinations for the Panel of Glycoproteins
Mass Glycan (%) Expecteda SLSb DLSc I(0) (water) I(0) (stds) SAXS MoWd Autoporodd N-PAGE SECe
Lysozyme 0 14.3 14.3 10.6 ± 0.8 12.7 10.9 8.6 11 ND 3.4
RNaseA 0 13.7 15.1 10.3 ± 1 15.9 ND 9.9/9.9 10.3/10 ND 10.7
RNaseB 9.1 15.1 15.3 13 ± 1.4 16.8 14.8 10.4/12.2 11.4/11.6 ND 13.5
a1AGP 40.2 36.1 35.2 46.1 ± 1.5 35.9 34.0 41.8/39.4 60.7/56.5 38.3 75.2
Fetuin 23.6 47.6 48 65 ± 2.1 46.9 42.7 49.4/44.9 65/65.2 75.8 111.1
17b IgG Fc 6.0 53.6 62.5 56.6 ± 2.1 57.9 60.2 51.1 47.1 Smear 46.2
BHA 17.2 203.7 184.7 204.6 ± 6.4 194.5 183.6 176.0 252.8 322 316.2
Molecular mass determinations are shown in kDa.
aMW calculated for the most abundant glycoforms.
bMW estimated from static light scattering. Uncertainty in this measurement is primarily dependent on the uncertainty in concentration determination,
expected to be <15%.
cMW estimation (average ± SD) from dynamic light scattering assuming a spherical model.
dMW estimation from SAXSMoW using q range of 0–0.45 (Fischer et al., 2010). The second set of values for SAXSMow and Autoporod (Petoukhov
et al., 2007) were obtained from the FPLC-SAXS data sets. Uncertainty is expected to be around 10%.
eMW estimated from size exclusion chromatography.
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Molecular Mass Determination of Glycoproteins
Many classic techniques for MW determination of proteins and
complexes yield inaccurate estimates when applied to proteins
with significant glycan content (Lewis and Junghans, 2000;
Wen et al., 1996). In our analysis, the MWs estimated from size
exclusion chromatography and native polyacrylamide gel elec-
trophoresis (N-PAGE) are significantly off for proteins with high
glycan content, in some cases by a factor of two (Table 1). MW
estimates from dynamic light scattering, which assumed a
spherical model, were overall more accurate than size exclusion
chromatography (SEC) and N-PAGE, but the masses of several
glycoproteins were still overestimated. This is probably the
effect of flexible glycans contributing disproportionately to the
observed hydrodynamic radius and thus the inferred globular
MW. In contrast, accurate MW values are obtained by static light
scattering (SLS) for every sample examined.
An accurate MW derived from SAXS measurements is an
important check for ensuring that the data are usable for struc-
tural interpretation (Jacques and Trewhella, 2010). Several
methods have been established to calculate the MW from
SAXS data (Fischer et al., 2010; Mylonas and Svergun, 2007).
The MW determined using the SAXS intensity at zero angle,
I(0), relative to either water or a reference protein (in this case
RNaseA), appears to be accurate for glycoproteins, provided
that any contrast offset and differences in the partial specific
volume are accounted for (Table 1). On the other hand, MW
estimates of the glycoproteins from the Porod volume with auto-
porod (Petoukhov et al., 2007) were less accurate than those
obtained from I(0) because, as expected, Porod’s law and the
volume approximation break downwhen applied to noncompact
molecules with nonuniform scattering contrast (Mertens and
Svergun, 2010; Porod, 1982). The more recently developed
SAXSMoW calculation (Fischer et al., 2010) appears to provide
more accurate MW determination than autoporod. We note
that SAXSMoW calculations were far less accurate when the
data were truncated below q = 0.45 A˚1; therefore, data quality
at the higher angles seems critical for accuracy.322 Structure 21, 321–331, March 5, 2013 ª2013 Elsevier Ltd All righFrom the current SAXS I(0) and SLS MW determination, it is
clear that all of the proteins examined are monomeric in solution,
except for immunoglobulin G (IgG) Fc (dimer) and bromelain
cleaved hemagglutinin (BHA) (trimer). In contrast, the inaccurate
masses inferred from size exclusion chromatography, native
gels, and even autoporodwould lead one tomistakenly conclude
that several of these species are dimers. The unique case is the
Fc portion of human IgG, which shows a lower value with I(0) and
better accuracy with the Porod-based MW estimation. Unlike
most glycoproteins where the glycans are at the periphery of
the protein interacting with the solvent, the Fc domain has the
glycans positioned at the center of the molecule, forming
a part of the dimeric interface (Deisenhofer, 1981). The restrained
nature of these glycans results in a more compact molecule for
which the Porod-based MW approximation is suitable.
All-Atom Modeling with Well-Defined Templates
RNaseA/B
Bovine RNaseA and RNaseB serve as a useful comparison for
examining the scattering effect of glycans as the two proteins
differ only in that RNaseB has a single high-mannose type glycan
chain at N34. Furthermore, both RNaseA andRNaseB have been
shown by NMR spectroscopy and X-ray crystallography to have
highly similar protein structures (Williams et al., 1987). SAXS
analysis with online size exclusion chromatography resolved
monomeric RNaseA (Figure S1A available online) yielding an
Rg consistent with earlier reports (Mylonas and Svergun, 2007)
and a Porod volume and Dmax in good agreement with those
predicted from the NMR structure (Santoro et al., 1993) (Table
S1). The SAXS pattern is also consistent with the theoretical
scattering pattern calculated from the NMR ensemble of
RNaseA with a c of 1.47 ± 0.05 (Figure 1A).
The SAXS data for RNaseB showed a slightly larger Rg, Porod
volume, and Dmax, as expected due to the additional glycan
chain (Table S1). The Kratky plots of RNaseA and RNaseB are
similar, indicating a comparable degree of overall compactness
(Putnam et al., 2007) (Figure S3). Several structural ensembles of
RNaseB were generated with a range of high-mannose type
glycan chain sizes from three to nine mannose moieties to testts reserved
Figure 1. Comparison of Calculated SAXS Patterns from All-Atom
Modeling with Experimentally Measured Data for RNAseA Unglyco-
sylated and RNAseB Glycosylated
(A) SAXS profile of RNaseA (black circles) and the theoretical profile of the
best-fit model from the NMR ensemble (2AAS) (red).
(B) SAXS profile of RNaseB (black circles) with fits for the best model (lowest c,
red), poorest models (highest c, blue), and model of RNaseB without the
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Structure 21,the effect of glycan size on the fits to the scattering data. The
single best fits and overall c values from each ensemble show
that the models with five mannose groups (Man5) agree most
closely with the scattering data (Table S2). This is already
a promising result, as it is known that the Man5 glycoform is
the predominant glycoform in RNaseB, with Man6 through
Man9 in much lower abundance (Guttman, 1997).
A comparison of the best- and poorest-fitting RNaseB struc-
tures with a Man5 glycan indicates a clear difference in glycan
orientation (Figures 1B and 1C). In the ten best-fitting models
(c of 1.21 ± 0.02), the glycan chain protrudes outward from the
protein, whereas in the models with the worst fits (c of 5.98 ±
0.83), the glycan chain is localized close to the protein surface.
The glycan orientation revealed from the best-fitting models is
consistent with crystallographic studies, which concluded that
the glycan is relatively disordered and faces into a solvent void
in the crystal lattice (Williams et al., 1987).
Since several conformations may exist in solution, especially
for flexible systems, a single structural model may not accurately
fit the measured SAXS data. The minimal ensemble search
(MES) has been developed to find a combination of the smallest
possible number of structures that recapitulate the observed
SAXS pattern (Pelikan et al., 2009). For the present analyses,
MES was attempted to improve the fit, incorporating up to
five models from each ensemble. For RNaseB, MES led to no
improvement in the fit over the single best model. Taken
together, this indicates that, while there is probably high internal
flexibility within each glycosidic bond, the spatial occupancy of
the full glycan chain is relatively limited. One possible explana-
tion is the carbohydrates can achieve more favorable hydration
with the glycan protruding away from the protein. Alternatively,
weak interactions may constrain certain dihedrals at the base
of the glycan, constraining the overall orientation. Even if some
glycan dihedrals were rigid, the current methodology is of insuf-
ficient resolution for probing such details.
IgG Fc
The papain-cleaved constant domain (Fc) of human IgGwas also
isolated and examined. This molecule is a homodimer of the Fc2
and Fc3 domains with a single N-linked glycan on each subunit.
The crystal structure of IgG Fc includes the coordinates for the
entire glycan chain, which form contacts at the cavity between
the two Fc2 domains (Deisenhofer, 1981). Initial models of the
Fc domains based on the full coordinates in the crystal, including
the termini absent in the crystal, resulted in a c of 1.77 ± 0.04.
Ensembles were generated to probe a diverse occupancy of
the glycan chains. The resulting models with the glycans devi-
ating from the dimeric interface showed poorer agreement with
the measured SAXS data with c of 2.17 ± 0.21.
A wide array of fragment antigen binding (Fab) domains of IgG
have been structurally characterized and have shown distinct
‘‘elbow’’ angles (angle between Fv and Fc1). In a recent study,
these elbow motions were a requirement for Fab structures toglycan (cyan). Residual plots are shown below. Results of the top ten averages
(±SD) of the fits are reported in the inset. FPLC-SAXS traces and Guinier plots
are shown in Figures S1 and S3.
(C) Glycan positions are shown for the ten best (red) and poorest (blue) fitting
models.
See also Figures S1 and S2.
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2012). As the IgG Fc has a similar hinge between the second
and third constant domains (Fc2 and Fc3), a structural ensemble
was generated allowing hinge motions, while restraining glycans
to the crystal coordinates. Agreement with the SAXS data was
significantly improved with a c of 1.42 ± 0.03 (Figure 2A; Table
S2). Thus, for this glycoprotein, the sampling of the N-terminal
extension and elbow angle, rather than glycan positions, was
critical for generating accurate models. Although the sampling
of the ten residue N-terminal extension is broad, among best-
fitting models it consistently protrudes away from the protein,
rather than near the surface. The best models show some vari-
ance in the elbow angle, but MES did not lead to an appreciable
improvement in the fit (c of 1.35 versus 1.38 for the single best
model). This may highlight one limitation of SAXS, namely, that
several distinct structures can yield very similar SAXS patterns.
Despite this caveat, the analysis indicates that IgG Fc is not fixed
in the angle suggested by the crystal structure.
a1AGP
A step up in complexity, alpha-1-glycoprotein (a1AGP) provided
another useful test of our all-atom modeling approach since it
bears five complex type glycans and the nonglycosylated
protein structure has been determined (Scho¨nfeld et al., 2008).
The fully glycosylated form has previously been crystallized,
but diffraction was poor, presumably due to the relatively disor-
dered glycans (McPherson et al., 1984). Since the glycans don’t
seem to alter the tertiary structure (Friedman et al., 1986), models
were generated to sample glycan conformations, without any
flexibility permitted for the protein beyond the modified Asn resi-
dues and the N-terminal tail that was absent from the crystal
structures. The resulting structural ensemble of a1AGP with
glycans included several structures that were in reasonable
agreement with the SAXS data (c of 1.62 ± 0.06) (Figure 2B;
Table S2).
To test the effect of the glycan size on the resulting fits, the
same experimental data were fit to an additional ensemble omit-
ting all sialic acids (NeuAc) at the end of each glycan chain.
Modeling without NeuAc generated models with significantly
poorer fits than with NeuAc (2.27 ± 0.27 versus 1.62 ± 0.06),
with each ensemble sampling 200 models. The calculated Rg
from themodels without NeuAc (23.93 ± 0.25) is also less consis-
tent with the SAXS data than when NeuAc was included (25.56 ±
0.20; Rg obtained from SAXSwas 26.5 ± 0.06). Therefore, similar
to the RNaseB results, including the proper glycan type/size is
important for the accuracy of the resulting models.
While the modeling approach generates models consistent
with the SAXS data, comparisons of the best-fit models reveal
no apparent spatial convergence for any of the glycan chains.
MES resulted in an improvement in the fit (c 1.32 versus 1.52
for the best single model), indicating that several glycan
conformations more accurately describe the solution structure
of this system. Unlike with RNaseB, some or all of the glycan
chains in a1AGP may, in fact, have broad spatial sampling.
Additionally, the higher number of variables (five glycan chains
and an unresolved N terminus) will limit the likelihood of
capturing a single conformation that most accurately fits the
SAXS pattern, even with exhaustive ensemble sizes. However,
the fact that good fits are achieved with the glycosylated
models indicates that the protein structure in the nonglycosy-324 Structure 21, 321–331, March 5, 2013 ª2013 Elsevier Ltd All righlated crystal structure is consistent with that in the fully glyco-
sylated protein.
BHA
Influenza hemagglutinin is a trimeric viral surface protein that
catalyzes host-virus membrane fusion and contains several
glycans to shield itself from the host immune response. Although
the crystal structure of bromelain-released influenza hemagglu-
tinin (BHA) has been solved in its glycosylated form, the majority
of carbohydrate was not resolved, presumably due to inherent
flexibility and disorder (Wilson et al., 1981). Of the 200 all-atom
models generated including the full 21 glycans (per trimer), the
best ten were consistent with the SAXS data with a c of 1.77 ±
0.03 (Figure 2C). There was no clear spatial occupancy bias for
the glycans between the best- and worst-fitting models, and
MES for this system led to no significant improvement in the
goodness of fit over the best individual model (c 1.71 versus
1.73). As glycans chains decorate most of the protein surface,
changes in any single glycan may have only minor effects
on the overall fit. Therefore, for a system essentially coated in
glycan chains, our all-atom modeling approach can assess
whether or not the overall structure is consistent with SAXS
data but reveals little about the specific disposition of individual
glycans.
Modeling with Little Structural Information: Fetuin
Since no structural data exist for bovine fetuin, it serves as a good
system to test the limits of the all-atom modeling approach for
SAXS analysis. Along with the three complex type N-linked
glycans, the protein also contains four sites of O-linked glycosyl-
ation (Figure S2). The Kratky plot indicates that fetuin is mostly
awell-orderedglobulewith somedisorderedportions (FigureS3).
Based on sequence similarity, the protein has two cystatin
domains followed by a 100 residue C-terminal portion. Several
algorithms (DISEMBL, DisProt, PrDOS) predict that much of the
C-terminal region (residues 240–320) is intrinsically disordered
(Ishida and Kinoshita, 2007; Linding et al., 2003; Sickmeier
et al., 2007). HS-1, the human homolog of fetuin, is also known
to be proteolytically cleaved at the residues 280–317 (Nawratil
et al., 1996). The full sequence of fetuin was submitted to
I-TASSER along with disulfide restraints for in silico structure
prediction (Roy et al., 2010; Zhang, 2008). Low C scores of
4.54 and 4.95 for the top two models were achieved with a
relatively low clustering density (0.0049 and 0.0033), indicating
poor confidence in the models (predicted to be 0.24 ± 0.07 [TM
score] and 18.1 ± 2.4 A˚ [rmsd]). Nevertheless, the coordinates
from each of the five models were used as a template for gener-
atingglycosylated ensembles to compareagainst theSAXSdata.
Two out of the five ensembles produced structural models that
were in loose agreement with the SAXSdata (c of 2.06 ± 0.12 and
1.95 ± 0.16) (Figure 2D; Table S2). Since these templates have
significantly different protein structures, namely, a completely
different fold within the N-terminal cystatin domain, this presents
a limitation of the current methodology. With somany degrees of
freedom, it is possible to generate an array of distinct structures
with similar consistency to the scattering data. However, all of
the starting models without glycans had terrible fits to the
SAXS data (c > 15). Therefore, the incorporation of the glycans
into this type of analysis is essential. With additional restraints,
this approach could generate a more reliable model of this
glycoprotein.ts reserved
Figure 2. Comparison of Calculated SAXS Patterns from All-Atom Modeling with Experimentally Measured Data
SAXS profile and model fits for IgG Fc (A), a1AGP (B), BHA (C), and fetuin (D) with residual plots shown below. The resulting c values for each set are reported in
the insets and Table S2.
(A–C) Theoretical profiles of the best (red), worst (blue), and model without glycans (cyan) are fit against the SAXS data. Overlays of the top five models of each
ensemble are shown below the data sets as gray cartoons with glycans depicted as blue sticks.
(D) SAXS profile of fetuin with theoretical fits for the glycosylatedmodels using the top five structures from I-TASSER as templates. The top ten best-fittingmodels
are shown for each of the five templates. The two predicted cystatin domains (8–118 and 132–230) are shown in orange and cyan, respectively. The region
spanning 237–273, predicted to be intrinsically disordered is shown in red. The protease susceptible fragment 277–318 is shown in magenta. N-linked (blue) and
O-linked (purple) glycan chains are shown as sticks.
See also Figures S1 and S2.
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The most common method of extracting structural information
from SAXS data is the use of ab initio beadmodeling to construct
a shape envelope of the molecule consistent with the SAXS data
(Petoukhov and Svergun, 2007). Typically, several bead models
are calculated, aligned, and averaged to generate an average
low-resolution model of the molecule. Although this approach
can be useful for obtaining coarse-grain shape information, it is
not well suited for examining flexible molecules (Bernado´,
2010; Hammel, 2012). Though often attached to an ordered
protein substrate, glycans may contribute significant flexibility
to a system.We tested the general accuracy of ab initio modeling
for glycoproteins using two programs, DAMMIN and GASBOR.
Shape reconstruction was carried out for the RNaseA and
RNaseB data sets to examine the overall effects of the single
glycan chain. Both GASBOR and DAMMIN produced shape
envelopes for RNaseA that were convergent with normalized
spatial discrepancy (NSD) 0.63 ± 0.044 and 0.72 ± 0.01, respec-
tively (values under 1 are considered to indicate consistency
between the individual reconstructions). Docking the NMR
structure into the final averaged shape reconstruction showed
the expected shape and size for this protein (Figures 3A
and 3B). The same approach for the glycosylated RNaseB also
resulted in shape reconstructions with good convergence
(NSD of 0.62 ± 0.038 and 0.82 ± 0.013). For DAMMIN, the
composite, filtered shape envelope had a bulge proximal to the
glycan base (Figure 3C). However, the composite GASBOR
model showed only an overall larger envelope relative to
RNaseA with no clear bulge (Figure 3D). Several of the individual
GASBOR models showed glycan-like protrusions; however, the
relative feature locations were highly variable. The effects of
aligning and filtering the individual models appear to exclude
the variable glycan density from the final averaged model. These
results echo those reported for a study of Vitronectin, in which
the carbohydrates also contributed little to the overall modeled
shape (Lynn et al., 2005).
To test how ab initio reconstructions perform for a highly
glycosylated system, we ran the same bead modeling approach
on the a1AGP SAXS data. The final filtered shape envelope is
clearly larger than would be expected for the protein alone;
thus, the glycan density seems to be reconstructed at least
to some degree (Figures 3E and 3F). Convergence of both
GASBOR and DAMMIN ab initio shape reconstructions for
a1AGP is weaker than that for RNaseA and RNaseB models
(NSD 0.81 ± 0.04 and 1.50 ± 0.082, respectively), and it appears
that the glycan positions are highly ambiguous. Therefore,
beyond approximate shape of the molecule, little information
on the glycan arrangement is present in the bead models for
this system.
Last, we applied this approach to the fetuin data set, where it
would potentially be the most useful in the absence of any struc-
tural data. The consistency between the models was moderate
(NSDs 0.89 ± 0.04 and 1.55 ± 0.058 for DAMMIN and GASBOR,
respectively). Both reconstruction programs revealed a similar
overall elongated morphology with two lobes (Figures 3G and
3H). The best-fitting all-atom model of fetuin (from ensemble 4,
c 1.73) was docked into both composite envelopes. Although
our all-atom model of fetuin is speculative, the overall shape is
consistent with ab initio models, and therefore it may reflect326 Structure 21, 321–331, March 5, 2013 ª2013 Elsevier Ltd All righthe overall domain and glycan arrangement present in the solu-
tion structure.
In conclusion, even with all of the caveats limiting the ab initio
approach for glycoproteins, it generates the expected size and
a shape consistent with the protein substructure. For the exam-
ples studied here, the glycan positions cannot be effectively
visualized. Instead, glycans appear to contribute bulk volume
to the shape reconstructions or at best a bulge near the glycan
attachment site. Since the scattering contrast of the carbohy-
drate is significantly different from that of the protein, small angle
neutron scattering (SANS) with contrast matching should be an
effective way to directly resolve glycans (Whitten and Trewhella,
2009). A similar technique is possible for contrast matching with
SAXS; however, the high concentrations of solute required for
effective contrast matching would render the solution conditions
potentially nonphysiological and perturbing to protein structure
(Putnam et al., 2007).
Conclusions
We have demonstrated that the native MW of glycoproteins can
be accurately determined from SAXS, provided that the scat-
tering contrast and partial specific volume are properly taken
into account. Ab initio modeling can successfully determine
the shape of glycoproteins but provides little information about
the spatial occupancy of the glycans. For systems with known
coordinates for the protein component, an all-atom modeling
approach is a more effective way to interpret SAXS data,
potentially revealing the positioning of the glycans or regions
absent from the template structures. Although nearly all
glycoproteins are expected to have some degree of glycan
heterogeneity, modeling with the most abundant glycoform
appears sufficient for generating structures in agreement with
SAXS data. We have recently used this technique to identify
the disposition of the large V1/V2 loops of HIV gp120, a highly
glycosylated system (Guttman et al., 2012). With the new imple-
mentation of AllosMod (Weinkam et al., 2012) and FoXS
(Schneidman-Duhovny et al., 2010) servers, ensembles of glyco-
sylated conformations can be generated and fit against the
scattering data within minutes, allowing rapid sampling and
assessment of a wide range of glycoprotein conformations.
The web server can be found at http://salilab.org/
allosmod-foxs and has been set up to generate all types of
O-linked and N-linked glycans found in mammalian systems.
The approach will be valuable as SAXS data will be more readily
available with the application of high-throughput methodologies
(Hura et al., 2009).
EXPERIMENTAL PROCEDURES
Sample Preparation
Fetuin from calf serum, human a1AGP, and RNaseB from bovine pancreas
were purchased from Sigma Aldrich. Lysozyme was from MP Biomedicals
(Solon, OH) and bovine RNaseA was purchased from (Worthington Biochem-
icals). Each of these was repurified by size exclusion in PBS (20 mM sodium
phosphate [pH 7.4], 150 mM NaCl, 0.02% sodium azide, 1 mM EDTA). The
Fc portion of IgG 17b was prepared by treatment with papain (Thermo
Scientific, Rockville, MD) and isolated by size exclusion chromatography.
Hemagglutinin from X31 virus particles (Charles River, Wilmington, MA) was
cleaved with bromelain (Sigma Aldrich) as described in Compans et al.
(1970). Liberated BHA was separated from remaining particles by ultracentri-
fugation and purified by size exclusion chromatography (Superdex 200) in HBSts reserved
Figure 3. Ab Initio Shape Reconstruction of the Panel of Glycoproteins
Shape reconstructions of RNaseA (A and B), RNaseB (C and D), a1AGP (E and F), and fetuin (G and H) with averaged DAMMIN (left) and GASBOR (right) models
shown. Fits are shown in Figure S3. The envelopes were scaled to the measured Porod volume (listed in Table S2). For each protein the best (lowest c) all-atom
model was docked into both enantiomers of the final ab initio shape envelopes using SITUS, only the better enantiomer is shown (Wriggers and Birmanns, 2001).
(A–D) All-atom models RNaseA and RNaseB are shown as cartoons with glycans as sticks.
(E–H) The shape reconstructions calculated for the full glycoprotein (light gray) and only the protein substructure alone (dark gray) are shown for a1AGP (E and F)
a1AGP and fetuin (G and H) with N-linked glycans shown as blue sticks. The domains of fetuin are colored as described in Figure 2, with O-linked glycans shown
as purple sticks.
See also Figure S3.
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Structural Analysis of Glycoproteins by SAXS(10 mM HEPES [pH 7.4], 150 mM NaCl, 0.02% azide). Proteins were concen-
trated using microcentricon spin filters immediately before analysis (Amicon
10 kDa cutoff; Millipore, Billerica, MA). Sample purity was verified by SDS-
PAGE and N-PAGE.
Dynamic Light Scattering
Dynamic and static light scattering measurements were performed at 20C on
a Dynapro Nanostar (Wyatt Technology, Santa Barbara, CA). Thirty acquisi-
tions of 5 s were collected at a range of concentrations (0.1–1 mg/ml). Buffer
viscosity was calculated with SedNterp (Laue et al., 1992). Data were fit using
theWyatt Dynamics analysis software assuming a spherical model and adiffer-
ential index of refraction (dn/dc) of 0.185.
Small-Angle X-Ray Scattering
SAXS measurements were conducted on Beam Line 4-2 at the Stanford
Synchrotron Radiation Laboratory (Smolsky et al., 2007). The focused
11 keV X-ray beam irradiated a thin-wall quartz capillary cell, which contained
a sample aliquot, placed at 1.7 m upstream of the Rayonix MX 225HE detector
(Evanston, IL). The detector pixel numbers were converted to the momentum
transfer q = 4p*sinq/l, where 2*q is the scattering angle and l the X-ray wave-
length of 1.127 A˚, using a silver behenate powder standard placed at the
capillary position. A set of 16 consecutive 1 s X-ray exposures was made on
each sample aliquot at 15C with 15 ml oscillations (30 ml injected) between
exposures to minimize radiation damage. Protein scattering data were pro-
cessed by MarParse and scaled for the transmitted beam intensity integrated
for each exposure and azimuthally averaged (Smolsky et al., 2007). Exposures
were averaged with rejection criteria of 1.3 SDs relative to the initial exposure
to omit frames exhibiting radiation damage or other artifacts. Buffer scattering
data were processed in the same way and subtracted from corresponding
protein scattering data.
All samples were collected over a broad concentration range (0.25–
12 mg/ml). Data sets at the highest concentration free of self-association or
interparticle interference as reflected by the linearity of the Guinier regions
(QRg <1.3) were used for further analysis: lysozyme (1.5 mg/ml), RNaseA
(1.5 mg/ml), RNaseB (1.5 mg/ml), a1AGP (0.75 mg/ml), fetuin (1.5 mg/ml),
BHA (1.0mg/ml), and IgG Fc (1.3mg/ml). The 1DSAXS curves were processed
using GNOM to determine approximate Rg and Dmax values for the P(r) plots,
the pairwise distance distribution functions (Petoukhov and Svergun, 2007;
Svergun, 1991, 1992).
MWs were calculated for each sample using the zero angle scattering inten-
sity ‘‘I(0)’’ relative to water or RNaseA as a standard (Mylonas and Svergun,
2007). Partial specific volumes were calculated as the weighted average of
the protein component 0.7425 (Mylonas and Svergun, 2007), and that based
on the glycan from the known composition (Lewis and Junghans, 2000). Due
to the higher contrast difference (Dr) of glycans, the difference in contrast
















where I(0) is the scattering intensity at zero angle of the standard (std) and
protein (prot), C is the concentration, and v is the partial specific volume.
The Dr for glycoproteins was calculated as the difference of the weighted
average of protein (4.47 3 1023 e/cm3) and glycan (5.10 3 1023 e/cm3) from
the buffer (3.34 3 1023 e/cm3). Molecular weights were also calculated on
a relative scale using ‘‘SAXS MoW’’ (q up to 0.45 A˚1) (Fischer et al., 2010),
as well as from autoporod (Petoukhov et al., 2007).
Size exclusion directly online with SAXS (SEC-SAXS) was used to obtain
higher quality data sets for RNaseA, RNaseB, a1AGP, and fetuin. One hundred
microliters of each sample at 3–5 mg/ml were injected onto a highres
Sepharose 200 column (GE Healthcare) with a flow rate of 50 ml/min in PBS.
The flow was passed through the capillary cell and 1 s exposures were
collected every 5 s. Rg and I(0) for each frame were batch analyzed using
autoRg (Petoukhov et al., 2007), and frames with stable Rg values were
merged in primus (Konarev et al., 2003). Absorbance, I(0), and Rg values for328 Structure 21, 321–331, March 5, 2013 ª2013 Elsevier Ltd All righthe elution profiles are shown in Figure S1. The Rg values near the peak
shoulder showed no deviations, thus interparticle repulsion/association were
not evident under these conditions.
All-Atom Modeling of Glycoproteins
Ensembles of all-atom structural models were generated in MODELER (Sali
and Blundell, 1993) as an adaptation of previous work (Weinkam et al.,
2012). Initial structures were generated by addition of glycan chains with ideal
geometries derived from CHARMM (Guvench et al., 2008, 2009), followed by
a 1 A˚ randomization of the full atomic coordinates. The structures are first
relaxed with conjugate gradient steps followed by molecular dynamics
equilibration at 300K followed by several rounds of simulated annealing.
The procedure is repeated to produce 200 models for each protein (unless
otherwise stated). The intraprotein interactions consist of bonded (for stereo-
chemistry) and nonbonded (for excluded volume and atomic distance) terms
used in standard MODELER. The atomic distance term is a sum of harmonic
energy functions to restrain pairs of atoms relative to the template structure,
and this term is omitted for atoms within two residues of a glycosylation site
and for loops or termini absent in the template structure. Intraglycan interac-
tions consist of a bonded term that is a sum of harmonic energy functions
over all pairwise atomic distances within each sugar monomer. Bonds
between sugar monomers move with proper dihedral rotation using distance
and angle restraints. The full procedure can be accessed using our web server
at http://salilab.org/allosmod. Details of each glycoprotein template are listed
in the following subsections and site-specific glycan types are illustrated in
Figure S3.
Next, the theoretical profile from each structural model was calculated and
compared against the raw SAXS data using FoXS (Schneidman-Duhovny
et al., 2010). As there is still no ‘‘best’’ established method for this type of
comparison, we rely on the normalized discrepancy value (c) to evaluate the
goodness of fit (Putnam et al., 2007), as well as on a visual inspection of the
fit. Since c is heavily dependent on the error associated with themeasurement,
the metric is useful for comparing model SAXS patterns with experimentally
measured data within a given set, but less so between sets with different
experimental SAXS curves. For the current data sets, we consider a c of
1.0–1.5 a good fit, whereas c values above 2 indicate inconsistency between
the model and the SAXS data.
We also examine the average and SD among the ten best-fitting models
to assess the variance in c and establish whether or not different modeling
strategies result in significantly better fits to the same experimental profile.
This type of comparison depends on adequate conformational sampling,
which can be gauged by monitoring the best fit given increasingly larger
samples. For each data set, the sampling was doubled until the best fit
was not significantly better than previous data set (average of ten best fits
minus one SD). In all cases except fetuin, 200 models were adequate by this
criterion.
The ATSAS software package was used to predict Rg, Dmax, and envelope
volumes for each structural model (Svergun et al., 1995). Proper glycan stereo-
chemistry and linkage generated fromMODELERwere checked with PDBcare
(http://www.glycosciences.de/tools/pdb-care/) and glycosidic linkage angles
were analyzed by CARP (http://www.glycosciences.de/tools/carp) using the
GlycoMaps database (Lu¨tteke et al., 2005). Figures were made with PyMOL
(DeLano, 2002) and Chimera (Pettersen et al., 2004).
RNaseB
The sequence of bovine ribonuclease (RNase) (uniprot P61823) was modeled
utilizing coordinates from the crystal structure of RNaseB (Protein Data Bank
[PDB] 1RBB) (Williams et al., 1987) as well as the NMR structure of RNaseA
(PDB 2AAS) (Santoro et al., 1993).
IgG Fc
The IgG Fc portion of Ab 17b was modeled using the coordinates from the
crystal structure of IgG Fc (PDB 1FC1) (Deisenhofer, 1981), together with the
established disulfide connectivity for IgG. The coordinates for the complex
type glycan with a single (b1-4)Gal on the (1-6)Man were included in the align-
ment. The hinge region (339–343) between the Fc2 and Fc3 domains was left
unaligned to sample different elbow angles.ts reserved
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The sequence of a1AGP (uniprot P02763) was aligned to the sequence from
the recently available unglycosylated crystal structure of a1AGP (PDB 3KQ0
and 3APU) (Scho¨nfeld et al., 2008). Complex type tri and tetra-antennary
glycans containing (a2-6) terminal sialic acids were introduced at positions
(15, 38, 54, 75, and 85[tetra]) based on site-specific glycan studies (Imre
et al., 2005; Treuheit et al., 1992).
Fetuin
The mature sequence (uniprot: P12763) was submitted to I-TASSER structure
prediction (Roy et al., 2010; Zhang, 2008) with additional disulfide restraints
based on previous findings (Araki et al., 1989). All five I-TASSER models
were used as templates for MODELER runs, including triantennary sialylated
complex glycans at Asn 81, 138, and 158 and O-linked glycans at S253,
T262, S264, and S323, based on previous site specific studies (Edge and
Spiro, 1987; Guttman, 1997; Royle et al., 2002) (Figure S2).
Influenza Hemagglutinin
The sequence of the bromelain released ectodomain of influenza hemagglu-
tinin (BHA) (uniprot P03437) was threaded to the crystal structure (PDB
2HMG) (Wilson et al., 1981). High mannose and complex glycans were intro-
duced at positions as shown in Figure S2. The glycosylation at each of the 7
Asn sites was based on predominant glycoforms observed from liquid chro-
matography-tandemmass spectrometry analysis of peptic fragments (unpub-
lished data), which agree closely with earlier findings (Mir-Shekari et al., 1997).
Ab Initio Shape Reconstructions
The pairwise distance distribution function [P(r)] plot generated from GNOM
(Svergun, 1992) was used for ab initio shape reconstruction with DAMMIN
v5.3 and GASBOR22i (Svergun, 1999, 2001). The number of dummy residues
used for GASBOR calculations was increased to account for the difference in
scattering of glycans as described previously (Hammel et al., 2002). The bead
models were aligned using SUPCOMB13 with enantiomers considered (Kozin
and Svergun, 2001) and spatially filtered using DAMFILT (Volkov and Svergun,
2003). Plots of the resulting fits, Guinier plots, and P(r) plots are presented in
Figure S3.
Convergence of the models was assessed by the normalized spatial
discrepancy (NSD) showing values under 1, except for the GASBOR models
for a1AGP and fetuin with NSDs of 1.50 ± 0.082 and 1.55 ± 0.058, respectively.
Further refinement resulted in no improvement in c values and had no signifi-
cant effect on the resulting averaged models. GASBOR models showed
a greater variation of goodness of fit (c2) compared to the DAMMIN models.
Therefore, GASBOR models were ranked by goodness of fit (Svergun et al.,
2001), and only the top quartile aligned and averaged. The resulting models
were converted to a volume envelope using the program pdb2vol within the
SITUS2.2 package (Wriggers and Birmanns, 2001). All-atom models were
docked into both enantiomers of the volume envelope using the colores
module within SITUS2.2. Ab initio reconstructions of nonglycosylated fetuin
and a1AGP were performed starting with theoretical scattering pattern of the
protein substructure adding the same relative error present in the glycoprotein
SAXS data.
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